Enalapril is a potent angiotensin-converting enzyme (ACE) inhibitor widely used for the clinical management of hypertension, chronic heart failure, and diabetic nephropathy. By inhibiting the ACE enzyme,… Read more






































![Chemical structure of N-[1-(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanine-N-carboxyanhydride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F84793-24-8-N-1-S-Ethoxycarbonyl-3-phenylpropyl-L-alanine-N-carboxyanhydride.png&w=3840&q=75)







Enalapril is a potent angiotensin-converting enzyme (ACE) inhibitor widely used for the clinical management of hypertension, chronic heart failure, and diabetic nephropathy. By inhibiting the ACE enzyme, the drug prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby facilitating vasodilation and reducing blood pressure. This category provides a comprehensive selection of high-quality reference standards, including the active ingredient, its metabolites such as enalaprilat, and a variety of pharmacopeial and non-pharmacopeial impurities. These materials are essential for pharmaceutical laboratories conducting impurity profiling, method validation, and rigorous quality control testing. Furthermore, stable isotope labelled compounds are available to support precise quantitative analysis and facilitate complex stability studies. Each entry is characterized to ensure compliance with analytical requirements, providing the necessary precision for researchers engaged in degradation studies, genotoxicity screening, and the development of robust pharmaceutical testing methods.